Company news, research breakthroughs, and major announcements across industries.

Home/Science

Science |Arcus Biosciences

Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock

A

Arcus Biosciences, Inc. (NYSE: RCUS), a late clinical-stage biopharmaceutical company focused on developing differentiated molecules and combinations for the treatment of cancer and immune diseases, today announced the pricing of an underwritten public offering of 14,285,715 shares of its common stock at a price to the public of $17.50 per share. Gross proceeds to Arcus Biosciences from the offering are expected to be $250.0 million, before deducting underwriti...

  • PublishedOctober 21, 2026 · 10:53 PM
  • LocationHAYWARD, Calif.
  • IndustryScience
  • LanguageEN

Published by Business Wire. Read the original announcement for the full release.

Read the full announcement →

Latest from leading organizations

Explore recent announcements by organization